Creyon Bio
Pre-clinicalCreyon is a drug development company enabling tissue specific delivery of RNA therapies designed to improve safety, efficacy, and patient experience in immunology, central nervous system (CNS), and neuromuscular disease.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $120M
About
Creyon is a drug development company enabling tissue specific delivery of RNA therapies designed to improve safety, efficacy, and patient experience in immunology, central nervous system (CNS), and neuromuscular disease.
RNA & Gene Therapy
Funding History
2Total raised:$120M
Series A$80MNov 15, 2022
Seed$40MAug 15, 2021